Tadalafil Tablet, Film Coated
Product Images NDC 71205-754

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71205-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 01)

Chemical structure of tadalafil displayed as a molecular diagram featuring multiple ring systems, including a fused bicyclic system and a phenyl group with an attached furan ring.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 02)

This figure consists of four line graphs showing changes over time in blood pressure measurements: Standing Systolic BP, Standing Diastolic BP, Supine Systolic BP, and Supine Diastolic BP. The y-axis represents the difference in mmHg (Tadalafil minus Placebo), and the x-axis shows time in hours up to 96 hours. Each graph plots mean values with error bars.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 03)

A two-panel line graph depicting systolic blood pressure (BP) changes over 24 hours post-dose. The top panel shows standing systolic BP and the bottom panel shows supine systolic BP. Two treatments are compared: tadalafil 20 mg with doxazosin 8 mg versus placebo with doxazosin 8 mg. The x-axis represents time post-dose in hours, and the y-axis shows change in systolic BP in mmHg.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 04)

Line graph depicting changes in systolic blood pressure (mmHg) over 12 hours following administration of 20 mg tadalafil or placebo combined with 8 mg doxazosin at 08:00 or 20:00. The graph shows four data series comparing blood pressure effects at these times and treatments.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 05)

A line graph illustrating plasma tadalafil concentration (µg/L) over time (hours) for three dosing scenarios: a single 20-mg dose, a single 5-mg dose, and once-daily 5-mg dosing following 5 consecutive days. The y-axis represents plasma concentration and the x-axis shows time from 0 to 120 hours, with corresponding error bars indicating variability for each data point.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 06)

Line graph showing change from baseline in IPSS total score over treatment duration in weeks for tadalafil 5 mg and placebo groups. The tadalafil group shows a greater decrease in score compared to placebo, with statistical significance indicated at p<0.01.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 07)

A line graph showing the change from baseline in IPSS total score over 12 weeks of treatment, comparing tadalafil 5 mg and placebo. The x-axis represents treatment duration in weeks, while the y-axis shows the change in score. Tadalafil shows a greater reduction in IPSS score compared to placebo, with statistical significance indicated at certain time points.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 08)

A line graph showing least-squares mean change from baseline over 26 weeks of therapy. It compares tadalafil/finasteride treatment to placebo/finasteride at weeks 4, 12, and 26, with marked differences in mean change and significance annotations (p<0.001 and p<0.05) noted at specific time points.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 09)

A line graph showing change from baseline in IPSS Total Score over a 12-week treatment duration. Two lines compare tadalafil 5 mg and placebo, with tadalafil showing a greater decrease over time. The x-axis represents duration of treatment in weeks, and the y-axis shows change from baseline in IPSS Total Score. Statistical significance (p<0.01) is indicated.*

FDA Label Image

Unichem Logo (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 10)

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 11)

FDA Label Image

71205-754-30 (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 15)

Tadalafil 5 mg film-coated tablets label primarily from Proficient Rx LP. The label indicates a bottle of 30 tablets, each containing 5 mg of tadalafil USP. Tablets are described as yellow, almond-shaped, film-coated, debossed with "287" on one side and "U" on the other. Manufacturer is Unichem Laboratories Ltd, India, with storage instructions at 20°-25°C (68°-77°F). Includes barcode, NDC 71205-754-30, and multiple small repeat labels with lot and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.